Neurophysiological Study of Sativex in Multiple Sclerosis (MS) Spasticity

Summary

Aim of this randomized, double-blind, placebo-controlled, cross-over study is to investigate cannabinoid-induced changes in neurophysiological parameters in a group of 40 patients with secondary or primary progressive Multiple Sclerosis (MS).

Timeline

Start

2012-04

Primary completion

2013-11

Completion

2013-11

Drugs

Indications